Obolensky A - Search Results

1

Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia.

Ofri R, Averbukh E, Ezra-Elia R, Ross M, Honig H, Obolensky A, Rosov A, Hauswirth WW, Gootwine E, Banin E. Ofri R, et al. Among authors: obolensky a. Hum Gene Ther. 2018 Dec;29(12):1376-1386. doi: 10.1089/hum.2018.076. Epub 2018 Jul 30. Hum Gene Ther. 2018. PMID: 29926749

2

Gene delivery by viral vectors in primary cultures of lacrimal gland tissue.

Banin E, Obolensky A, Piontek E, Falk H, Pikarsky E, Pe'er J, Panet A, Chowers I. Banin E, et al. Among authors: obolensky a. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1529-33. doi: 10.1167/iovs.02-0529. Invest Ophthalmol Vis Sci. 2003. PMID: 12657589

3

Retinal function abnormalities in patients treated with vigabatrin.

Banin E, Shalev RS, Obolensky A, Neis R, Chowers I, Gross-Tsur V. Banin E, et al. Among authors: obolensky a. Arch Ophthalmol. 2003 Jun;121(6):811-6. doi: 10.1001/archopht.121.6.811. Arch Ophthalmol. 2003. PMID: 12796251

4

Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard.

Banin E, Morad Y, Berenshtein E, Obolensky A, Yahalom C, Goldich J, Adibelli FM, Zuniga G, DeAnda M, Pe'er J, Chevion M. Banin E, et al. Among authors: obolensky a. Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2966-72. doi: 10.1167/iovs.02-1164. Invest Ophthalmol Vis Sci. 2003. PMID: 12824239

5

Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids.

Morad Y, Banin E, Averbukh E, Berenshtein E, Obolensky A, Chevion M. Morad Y, et al. Among authors: obolensky a. Invest Ophthalmol Vis Sci. 2005 May;46(5):1640-6. doi: 10.1167/iovs.04-1165. Invest Ophthalmol Vis Sci. 2005. PMID: 15851563

6

Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells.

Banin E, Obolensky A, Idelson M, Hemo I, Reinhardtz E, Pikarsky E, Ben-Hur T, Reubinoff B. Banin E, et al. Among authors: obolensky a. Stem Cells. 2006 Feb;24(2):246-57. doi: 10.1634/stemcells.2005-0009. Epub 2005 Aug 25. Stem Cells. 2006. PMID: 16123388

7

Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.

Kaiserman N, Obolensky A, Banin E, Sharon D. Kaiserman N, et al. Among authors: obolensky a. Arch Ophthalmol. 2007 Feb;125(2):219-24. doi: 10.1001/archopht.125.2.219. Arch Ophthalmol. 2007. PMID: 17296898

8

Homozygosity for a novel ABCA4 founder splicing mutation is associated with progressive and severe Stargardt-like disease.

Beit-Ya'acov A, Mizrahi-Meissonnier L, Obolensky A, Landau C, Blumenfeld A, Rosenmann A, Banin E, Sharon D. Beit-Ya'acov A, et al. Among authors: obolensky a. Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4308-14. doi: 10.1167/iovs.07-0244. Invest Ophthalmol Vis Sci. 2007. PMID: 17724221

9

Ischemic preconditioning of the rat retina: protective role of ferritin.

Obolensky A, Berenshtein E, Konijn AM, Banin E, Chevion M. Obolensky A, et al. Free Radic Biol Med. 2008 Apr 1;44(7):1286-94. doi: 10.1016/j.freeradbiomed.2007.10.060. Epub 2007 Nov 21. Free Radic Biol Med. 2008. PMID: 18082149

10

A novel day blindness in sheep: epidemiological, behavioural, electrophysiological and histopathological studies.

Shamir MH, Ofri R, Bor A, Brenner O, Reicher S, Obolensky A, Averbukh E, Banin E, Gootwine E. Shamir MH, et al. Among authors: obolensky a. Vet J. 2010 Aug;185(2):130-7. doi: 10.1016/j.tvjl.2009.05.029. Epub 2009 Jul 9. Vet J. 2010. PMID: 19546015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters